Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis

NCT04163419 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Schwannomatosis
Pain

Interventions

DRUG: Tanezumab
DRUG: Placebo

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]